Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (3824)	2/14/1998 12:43:00 AM
From: JOHN W.	Read Replies (1) of 6136

"Last month F. Hoffmann-La Roche (ROCZg.S) and Agouron Pharmaceuticals Inc (AGPH - news) of California dropped work on an MMP inhibitor because they said it wasn't sufficiently superior to existing therapies to justify further investment." This was the first part of mis information. It was not 20,000 but 2k. More misinformation. Margie, the 3 of the 109 were switched from Crix to Viracept. This obviously is a small percentage even if nelf caused the Crix bellly. Just thought you should know. I have lost a lot of money on AGPH, so I get rather upset when I see this type of manipulation with misinformation.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next